The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Genomic Research Centers
Agency: National Institutes of Health
- 93.847 -- Diabetes, Digestive, and Kidney Diseases Extramural Research
Forecasted opportunityLast Updated: May 13, 2026
Important dates
- Forecasted post date: August 1, 2026
- Forecasted application due date: November 1, 2026
- Forecasted award date: July 1, 2027
- Forecasted project start date: July 1, 2027
- Fiscal Year: 2027
Award details
- Expected project funding: $6,400,000
- Expected awards: 9
Award min.
Not specified
Award max.
Not specified
- Funding opportunity number:RFA-DK-27-116
- Cost sharing or matching requirement:No
- Funding instrument type:
- Cooperative agreement
- Opportunity Category:Discretionary
- Opportunity Category Explanation:Not specified
- Category of Funding Activity:
- Health
- Category Explanation:Not specified
History
- Forecast posted date: September 18, 2025
- Archive date: Not specified
- Version: 1
Summary
The National Institute of Diabetes and Digestive Diseases and Nutrition (NIDDK) seeks to advance its mission by continuing the NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC). The IBDGC has led collaborative efforts resulting in the identification of >300 genetic risk loci for different IBD subtypes across patient populations and characterization of underlying biological mechanisms. Despite advances in biological understanding and the development of a range of biologic therapies, IBD remains a chronic, severe and heterogenous disease with no cure requiring multiple interventions over the life course. Diagnostic biomarkers and accurate predictors of critical outcomes including disease remission, recurrence, and response to specific therapies are lacking. The IBDGC will leverage patient cohorts, biospecimens and advances in data science to characterize the interactions of genetic, clinical and environmental factors in disease development and progression, and to develop new predictors of disease outcomes, with the goal of improving medical management and advancing precision medicine for IBD patients. The IBDGC may include up to 7 Genomic Research Centers with varying research emphases, which will serve as sites for participant enrollment, molecular analysis of biospecimens and bioinformatics and computational analyses.
Eligibility
Miscellaneous
- Other
Business
- For-profit organizations other than small businesses
- Small businesses
Government
- County governments
- State governments
- Special district governments
- Public and Indian housing authorities
- City or township governments
- Federally recognized Native American tribal governments
Education
- Independent school districts
- Public and state institutions of higher education
- Private institutions of higher education
Nonprofit
- Other Native American tribal organizations
- Nonprofits non-higher education with 501(c)(3)
Additional information on eligibility
Documents
No documents are currently available.
Agency contact information
Email: Ludmila.pawlikowska@nih.gov
Ludmila.pawlikowska@nih.gov
Link to additional information
No additional information is available
